Treatment of active psoriatic arthritis with the PPARgamma ligand pioglitazone: an open-label pilot study - Bongartz,T.; Coras,B.; Vogt,T.; Scholmerich,J.; Muller-Ladner,U. (Rheumatology (Oxford), 2005)